Jian Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jian Zhou has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Zengjie Ye
School of Nursing, Guangzhou Medical University, Guangzhou, China
3 shared publications Hongman Li
School of Nursing, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China
2 shared publicationsBeibei Cheng
Thyroid and Breast Department, Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University), Zhuhai, Guangdong Province, China
1 shared publication- Jiaying Li
The Nethersole School of Nursing, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China
1 shared publication Keqing Cai
The First School of Clinical Medicine of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China
1 shared publication- Lin Luo
First School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China
1 shared publication
Latest Publications
- Open Access
- 11 October 2025
- Published by Elsevier in Asia-Pacific Journal of Oncology Nursing
- Vol. 12, 100803
Demoralization and dignity loss in breast cancer: A network analysis and computer simulation study
- 11 October 2025
- Published by Elsevier in Asia-Pacific Journal of Oncology Nursing
- Vol. 12, 100803
Open AccessDemoralization and dignity loss in breast cancer: A network analysis and computer simulation study
- Top Cited PapersOpen Access
- 27 March 2025
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 16, 1521555
Association between fear of cancer recurrence and emotional distress in breast cancer: a latent profile and moderation analysis
Background: Breast cancer patients often experience significant psychological challenges, particularly fear of cancer recurrence (FCR), which is a prevalent and distressing concern following diagnosis. FCR can lead to heightened emotional distress, including anxiety and depression. Resilience, the ability to adapt positively to adversity, may play a crucial role in mitigating these negative emotional outcomes. This study aims to explore the heterogeneity of FCR among breast cancer patients and examine the moderating effect of resilience on the relationship between FCR and emotional distress.Materials and methods: A cohort of 398 breast cancer patients participated in the Be Resilient to Breast Cancer (BRBC) program between May and December 2023. Surveys were administered to assess FCR, resilience, and emotional distress levels. Data were analyzed using two approaches: latent profile analysis (LPA) to identify distinct FCR profiles and moderation analysis to evaluate the role of resilience.Results: Three distinct FCR profiles were identified: low (27.5%), middle (53%), and high (19.5%). Resilience significantly moderated the association between FCR and anxiety (B = 0.115, SE = 0.046, P = 0.014), but no significant moderating effect was observed for depression.Discussion: The findings highlight significant heterogeneity in FCR among breast cancer patients, with a substantial proportion experiencing moderate to high levels of FCR. Resilience was found to buffer the impact of FCR on anxiety, suggesting that interventions aimed at enhancing resilience could alleviate anxiety related to FCR in this population. These results underscore the importance of incorporating resilience-focused strategies into psychological therapies for breast cancer patients.
- 27 March 2025
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 16, 1521555
Top Cited PapersOpen AccessAssociation between fear of cancer recurrence and emotional distress in breast cancer: a latent profile and moderation analysis
Background: Breast cancer patients often experience significant psychological challenges, particularly fear of cancer recurrence (FCR), which is a prevalent and distressing concern following diagnosis. FCR can lead to heightened emotional distress, including anxiety and depression. Resilience, the ability to adapt positively to adversity, may play a crucial role in mitigating these negative emotional outcomes. This study aims to explore the heterogeneity of FCR among breast cancer patients and examine the moderating effect of resilience on the relationship between FCR and emotional distress.Materials and methods: A cohort of 398 breast cancer patients participated in the Be Resilient to Breast Cancer (BRBC) program between May and December 2023. Surveys were administered to assess FCR, resilience, and emotional distress levels. Data were analyzed using two approaches: latent profile analysis (LPA) to identify distinct FCR profiles and moderation analysis to evaluate the role of resilience.Results: Three distinct FCR profiles were identified: low (27.5%), middle (53%), and high (19.5%). Resilience significantly moderated the association between FCR and anxiety (B = 0.115, SE = 0.046, P = 0.014), but no significant moderating effect was observed for depression.Discussion: The findings highlight significant heterogeneity in FCR among breast cancer patients, with a substantial proportion experiencing moderate to high levels of FCR. Resilience was found to buffer the impact of FCR on anxiety, suggesting that interventions aimed at enhancing resilience could alleviate anxiety related to FCR in this population. These results underscore the importance of incorporating resilience-focused strategies into psychological therapies for breast cancer patients.
- 13 March 2024
- Published by Elsevier in European Journal of Oncology Nursing
- Vol. 70, 102566
Sentinel and networked symptoms in patients with breast cancer undergoing chemotherapy
- 13 March 2024
- Published by Elsevier in European Journal of Oncology Nursing
- Vol. 70, 102566
Sentinel and networked symptoms in patients with breast cancer undergoing chemotherapy
- Open Access
- 8 March 2024
- Published by Elsevier in Asia-Pacific Journal of Oncology Nursing
- Vol. 11 (4) , 100436
Prevalence and clinical outcomes of sarcopenia in patients with esophageal, gastric or colorectal cancers receiving preoperative neoadjuvant therapy: A meta-analysis
- 8 March 2024
- Published by Elsevier in Asia-Pacific Journal of Oncology Nursing
- Vol. 11 (4) , 100436
Open AccessPrevalence and clinical outcomes of sarcopenia in patients with esophageal, gastric or colorectal cancers receiving preoperative neoadjuvant therapy: A meta-analysis